Trade Ocugen, Inc. - OCGN CFD
What is Ocugen, Inc. (OCGN)?
Ocugen, Inc. is a biopharmaceutical company specializing in the development of gene therapies and vaccines. The company focuses on treatments for rare diseases and ophthalmic conditions, aiming to address unmet medical needs. Ocugen's research includes the development of innovative therapies using gene editing and other advanced biotechnologies. It operates within the biotechnology and pharmaceutical industries, engaging in partnerships and collaborations to advance its product pipeline. The company is involved in clinical development programs and regulatory processes to bring its therapies to market. Ocugen is based in the United States and contributes to the field of genetic medicine through its scientific and clinical efforts.
Ocugen, Inc. Stock Price Today: Live Overview
The price today is shaped by market movement, as Ocugen, Inc. registers at $1.7842. The intraday price range extends from $1.7058 to $1.7958, reflecting a daily change of +0.56%.
FAQ: Ocugen, Inc. (OCGN)
What is the current price of OCGN stock?
The current trading price is $1.7842.
Does OCGN pay dividends?
Ocugen, Inc. does not issue dividends at this time.
Does OCGN have a formal corporate presence or regional headquarters in the UAE?
Ocugen, Inc. does not have an official office or subsidiary in the UAE and operates via local partners and distributors.
What is OCGN best known for?
Ocugen, Inc. is most famous for its work in developing gene therapies and vaccines.
What assets are typically shown together with OCGN?
Commonly shown alongside OCGN: Hilton Food Group, Vanguard U.K. Gilt UCITS ETF, Invesco S&P 100 Equal Weight ETF
Latest shares articles
Ratings and Reviews
Ratings and Reviews
